Cargando…
Acetazolamide reduces exercise capacity following a 5-day ascent to 4559 m in a randomised study
OBJECTIVE: To assess whether acetazolamide (Az), used prophylactically for acute mountain sickness (AMS), alters exercise capacity at high altitude. METHODS: Az (500 mg daily) or placebo was administered to 20 healthy adults (aged 36±20 years, range 21–77), who were paired for age, sex, AMS suscepti...
Autores principales: | Bradwell, Arthur R, Ashdown, Kimberley, Rue, Carla, Delamere, John, Thomas, Owen D, Lucas, Samuel J E, Wright, Alex D, Harris, Stephen J, Myers, Stephen D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783038/ https://www.ncbi.nlm.nih.gov/pubmed/29387446 http://dx.doi.org/10.1136/bmjsem-2017-000302 |
Ejemplares similares
-
Serum neurofilament level increases after ascent to 4559 m but is not related to acute mountain sickness
por: Sareban, Mahdi, et al.
Publicado: (2020) -
Impairment of left atrial mechanics does not contribute to the reduction in stroke volume after active ascent to 4559 m
por: Sareban, Mahdi, et al.
Publicado: (2018) -
Hypoxia is not the primary mechanism contributing to exercise-induced proteinuria
por: Joyce, Kelsley E, et al.
Publicado: (2020) -
Effect of losartan on performance and physiological responses to exercise at high altitude (5035 m)
por: Lucas, Samuel J E, et al.
Publicado: (2021) -
Steady‐state chemoreflex drive captures ventilatory acclimatization during incremental ascent to high altitude: Effect of acetazolamide
por: Cates, Valerie C., et al.
Publicado: (2022)